Clinical practice guidelines in oncology

Shaji K. Kumar; Natalie S. Callander; Melissa Alsina; Djordje Atanackovic; J. Sybil Biermann; Jason C. Chandler; Caitlin Costello; Matthew Faiman; Henry C. Fung; Cristina Gasparetto; Kelly Godby; Craig Hofmeister; Leona Holmberg; Sarah Holstein; Carol Ann Huff; Adetola Kassim; Michaela Liedtke; Thomas Martin; James Omel; Noopur Raje; Frederic J. Reu; Seema Singhal; George Somlo; Keith Stockerl-Goldstein; Steven P. Treon; Donna Weber; Joachim Yahalom; D. A. Shead; Rashmi Kumar

doi:10.6004/jnccn.2017.0023

Clinical practice guidelines in oncology

Shaji K. Kumar, Natalie S. Callander, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jason C. Chandler, Caitlin Costello, Matthew Faiman, Henry C. Fung, Cristina Gasparetto, Kelly Godby, Craig Hofmeister, Leona Holmberg, Sarah Holstein, Carol Ann Huff, Adetola Kassim, Michaela Liedtke, Thomas Martin, James Omel, Noopur RajeFrederic J. Reu, Seema Singhal, George Somlo, Keith Stockerl-Goldstein, Steven P. Treon, Donna Weber, Joachim Yahalom, D. A. Shead, Rashmi Kumar

Research output: Contribution to journal › Article › peer-review

159 Scopus citations

Abstract

Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenström's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.

Original language	English
Pages (from-to)	230-269
Number of pages	40
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	15
Issue number	2
DOIs	https://doi.org/10.6004/jnccn.2017.0023
State	Published - Feb 1 2017

Access to Document

10.6004/jnccn.2017.0023

Cite this

Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Chandler, J. C., Costello, C., Faiman, M., Fung, H. C., Gasparetto, C., Godby, K., Hofmeister, C., Holmberg, L., Holstein, S., Huff, C. A., Kassim, A., Liedtke, M., Martin, T., Omel, J., ... Kumar, R. (2017). Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 15(2), 230-269. https://doi.org/10.6004/jnccn.2017.0023

@article{e9a39630b54f466189e7fa82ad8523a5,

title = "Clinical practice guidelines in oncology",

abstract = "Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenstr{\"o}m's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.",

author = "Kumar, {Shaji K.} and Callander, {Natalie S.} and Melissa Alsina and Djordje Atanackovic and Biermann, {J. Sybil} and Chandler, {Jason C.} and Caitlin Costello and Matthew Faiman and Fung, {Henry C.} and Cristina Gasparetto and Kelly Godby and Craig Hofmeister and Leona Holmberg and Sarah Holstein and Huff, {Carol Ann} and Adetola Kassim and Michaela Liedtke and Thomas Martin and James Omel and Noopur Raje and Reu, {Frederic J.} and Seema Singhal and George Somlo and Keith Stockerl-Goldstein and Treon, {Steven P.} and Donna Weber and Joachim Yahalom and Shead, {D. A.} and Rashmi Kumar",

note = "Publisher Copyright: {\textcopyright}copy;JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2017",

month = feb,

day = "1",

doi = "10.6004/jnccn.2017.0023",

language = "English",

volume = "15",

pages = "230--269",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "2",

}

Kumar, SK, Callander, NS, Alsina, M, Atanackovic, D, Biermann, JS, Chandler, JC, Costello, C, Faiman, M, Fung, HC, Gasparetto, C, Godby, K, Hofmeister, C, Holmberg, L, Holstein, S, Huff, CA, Kassim, A, Liedtke, M, Martin, T, Omel, J, Raje, N, Reu, FJ, Singhal, S, Somlo, G, Stockerl-Goldstein, K, Treon, SP, Weber, D, Yahalom, J, Shead, DA & Kumar, R 2017, 'Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 2, pp. 230-269. https://doi.org/10.6004/jnccn.2017.0023

TY - JOUR

T1 - Clinical practice guidelines in oncology

AU - Kumar, Shaji K.

AU - Callander, Natalie S.

AU - Alsina, Melissa

AU - Atanackovic, Djordje

AU - Biermann, J. Sybil

AU - Chandler, Jason C.

AU - Costello, Caitlin

AU - Faiman, Matthew

AU - Fung, Henry C.

AU - Gasparetto, Cristina

AU - Godby, Kelly

AU - Hofmeister, Craig

AU - Holmberg, Leona

AU - Holstein, Sarah

AU - Huff, Carol Ann

AU - Kassim, Adetola

AU - Liedtke, Michaela

AU - Martin, Thomas

AU - Omel, James

AU - Raje, Noopur

AU - Reu, Frederic J.

AU - Singhal, Seema

AU - Somlo, George

AU - Stockerl-Goldstein, Keith

AU - Treon, Steven P.

AU - Weber, Donna

AU - Yahalom, Joachim

AU - Shead, D. A.

AU - Kumar, Rashmi

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenström's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.

AB - Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenström's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=85016214542&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0023

DO - 10.6004/jnccn.2017.0023

M3 - Article

C2 - 28188192

AN - SCOPUS:85016214542

SN - 1540-1405

VL - 15

SP - 230

EP - 269

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 2

ER -

Clinical practice guidelines in oncology

Abstract

Access to Document

Other files and links

Fingerprint

Cite this